Cure My Disease

Don't miss your cure!

 Log in / Sign up

Diabetes drug under watch: Real-World safety check in korea

NCT ID NCT04952779

Completed Disease control Sponsor: Novo Nordisk A/S Source: ClinicalTrials.gov ↗

Summary

This study monitored the safety and effectiveness of Xultophy, a combination diabetes medication, in routine medical practice. About 750 adults with type 2 diabetes in Korea who were prescribed Xultophy by their doctors were observed for 26 weeks. The research aimed to see how well the medication worked and what side effects occurred during normal use, not in a controlled trial setting.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Ajou University Hospital

    Gyeonggi-do, 16499, South Korea

  • Chungbuk National University Hospital

    Daejeon, 361-711, South Korea

  • Daejeon Endo Internal Medicine Clinic

    Daejeon, Cheongsa-ro, Seo-gu, 35220, South Korea

  • Daejeon Endo Internal Medicine Clinic

    Daejeon, 35220, South Korea

  • Dongguk University Ilsan Hospital

    Goyang, 10326, South Korea

  • Dongtan Jeil Women's Hospital

    Gyeonggi-do, 18450, South Korea

  • Eulji University Hospital_Daejeon

    Daejeon, 302-120, South Korea

  • Gyeongsang National University Hospital

    Gyeongsangnam-do, 52727, South Korea

  • Hanil General Hospital

    Seoul, 01450, South Korea

  • Hyewon Medical Foundation Sejong General Hospital

    Gyeonggi-do, 14754, South Korea

  • Inha University Hospital

    Incheon, 22332, South Korea

  • Inje University Busan Paik Hospital

    Busan, 47392, South Korea

  • Inje University Seoul Paik Hospital

    Seoul, 04551, South Korea

  • Isam Hospital

    Busan, 47354, South Korea

  • Jae Clinic

    Seoul, 08226, South Korea

  • Jeonbuk National University Hospital

    Jeonju, Jeollabuk-do, 54907, South Korea

  • KangNam Sacred Heart Hospital

    Seoul, 07441, South Korea

  • Keimyung University Dongsan Hospital

    Daegu, 42601, South Korea

  • Keimyung University Dongsan Medical Center

    Daegu, 42601, South Korea

  • Kosin University Gospel Hospital

    Busan, 49267, South Korea

  • Kyung Hee University Hospital at Gangdong

    Seoul, 05278, South Korea

  • Nowon Eulji Medical Center, Eulji University

    Seoul, 01830, South Korea

  • Sahm Yook Medical Center

    Seoul, 02500, South Korea

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, 13620, South Korea

  • Soon Chun Hyang University Hospital Cheonan

    Cheonan, Chungcheongnam-do, 31151, South Korea

  • The Catholic University of Korea, ST. Vincent's Hospital

    Suwon, Gyeonggi-do, 16247, South Korea

  • The Catholic University of Korea, Seoul ST. Mary's Hospital

    Seoul, 06591, South Korea

  • The Catholic University of Korea, Yeouido ST. Mary's Hospital

    Seoul, 07345, South Korea

  • Uijeongbu Eulji university Hospital

    Uijeongbu-si, 11759, South Korea

  • Ulsan Hospital

    Ulsan, 44686, South Korea

  • Ulsan University Hospital

    Ulsan, 682-060, South Korea

  • Yonsei Leehyunchul Internal Medicine

    Seoul, 04058, South Korea

Conditions

Explore the condition pages connected to this study.

DIABETES MELLITUS, TYPE 2